SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Septerna, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$36.38+0.03 (+0.08%)
Close on Oct 19, 2026
- Market cap
- $1.64B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$14.32 (+64.91%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Septerna, Inc. grew revenue 13520.1% to $98.88M over the twelve months to Jun 30, 2026. Free cash flow was $105.10M.
Revenue
$98.88M
+13520.1% vs. a year earlier
Operating income
-$43.55M
TTM Q2 2026
Free cash flow
$105.10M
TTM Q2 2026
EPS, diluted
-$0.54
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.64B
- P/E ratio
- –
- Price to sales
- 16.57
- Price to book
- 4.24
- Dividend yield
- –
- Free cash flow yield
- 6.41%
Fundamentals
- Revenue
- $98.88M
- Net income
- -$24.24M
- EPS, diluted
- -$0.54
- Free cash flow
- $105.10M
- Book value per share
- $8.59
- Diluted shares
- 45M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$98.88M+13520.1% YoY
Operating income
-$43.55M
Net income
-$24.24M
EPS, diluted
-$0.54
Free cash flow
$105.10M
Reported periodTrailing twelve months